Primary Health Properties PLC

Report Publication Announcement • Jan 12, 2024

National Storage Mechanism | Additional information

RNS Number : 4391Z

Primary Health Properties PLC

12 January 2024

Primary Health Properties PLC

(Incorporated in the United Kingdom)

Company Number: 3033634

LSE Share Code: PHP

JSE Share Code: PHP

ISIN Code: GB00BYRJ5J14

LEI: 213800Y5CJHXOATK7X11

("PHP" or the "Company")

Notice of Preliminary Results

Primary Health Properties PLC (LSE: PHP), one of the UK's leading investors in modern primary healthcare facilities, will announce its preliminary results for the year ended 31 December 2023 on Wednesday, 28 February 2024.

A presentation for analysts will be held at Buchanan Communications on the day of results at 9.30am UK time (11.30am SAST) and will also be accessible via live video webcast and a live conference call facility. Following the presentation there will be a moderated Q&A session.

To access the briefing, please log on or dial in shortly before 09.30am UK time (11.30am SAST) via the details below:

Webcast:  https://stream.brrmedia.co.uk/broadcast/659e72fc277c2248ee137e83

Tel:                  UK-wide: +44 (0) 33 0551 0200

South Africa Toll Free: 0 800 980 512

Password:     Quote "PHP full year results" when prompted

If you would like to register your interest in attending the meeting, please contact Buchanan at php@buchanan.uk.com.

A recording of the webcast will be made available from c.12.00pm UK time (2.00pm SAST) on 28 February 2024 on the PHP website, https://www.phpgroup.co.uk/.

Further details:

Harry Hyman Chief Executive Officer Tel: 07973 344768	Richard Howell Chief Financial Officer Tel: 07766 072272
David Rydell / Stephanie Whitmore / Verity Parker Buchanan Communications Tel: +44 (0) 20 7466 5066

The Company has a primary listing on the London Stock Exchange and a secondary listing on the JSE Limited.

United Kingdom

[12] January 2024

Sponsor: PSG Capital

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORBBMITMTABBMI